PubRank

Priscilla A Furth

Author PubWeight™ 53.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 2007 10.49
2 The role of prolactin in mammary carcinoma. Endocr Rev 2003 2.95
3 Explant-cell culture of primary mammary tumors from MMTV-c-Myc transgenic mice. In Vitro Cell Dev Biol Anim 2004 1.71
4 Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers. Int J Cancer 2004 1.60
5 The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice. Cancer Res 2008 1.53
6 The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells. Mol Endocrinol 2005 1.52
7 Impaired meiotic DNA-damage repair and lack of crossing-over during spermatogenesis in BRCA1 full-length isoform deficient mice. Development 2003 1.49
8 Deregulated estrogen receptor alpha expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ. Cancer Res 2005 1.46
9 The PPARγ agonist efatutazone increases the spectrum of well-differentiated mammary cancer subtypes initiated by loss of full-length BRCA1 in association with TP53 haploinsufficiency. Am J Pathol 2013 1.45
10 Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. Endocr Rev 2008 1.38
11 Loss of Stat5a delays mammary cancer progression in a mouse model. Oncogene 2002 1.30
12 Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer. Oncogene 2005 1.19
13 Real-time imaging and characterization of human breast tissue by reflectance confocal microscopy. J Biomed Opt 2007 1.17
14 Comparison of mouse mammary gland imaging techniques and applications: reflectance confocal microscopy, GFP imaging, and ultrasound. BMC Cancer 2008 1.10
15 PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's Sarcoma tumorigenesis. Oncogene 2005 1.03
16 Introduction of estrogen receptor-alpha into the tTA/TAg conditional mouse model precipitates the development of estrogen-responsive mammary adenocarcinoma. Am J Pathol 2003 1.03
17 Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice. Mol Endocrinol 2004 1.00
18 Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis. Carcinogenesis 2010 0.94
19 BAX regulates follicular endowment in mice. Reproduction 2007 0.94
20 Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content. Mol Endocrinol 2011 0.92
21 Comparison of increased aromatase versus ERα in the generation of mammary hyperplasia and cancer. Cancer Res 2011 0.92
22 Effects of ERalpha overexpression on female reproduction in mice. Reprod Toxicol 2006 0.91
23 Effect of bilateral oophorectomy on mammary tumor formation in BRCA1 mutant mice. Oncol Rep 2005 0.91
24 Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia. Cancer Res 2010 0.90
25 Reflectance confocal microscopy for characterization of mammary ductal structures and development of neoplasia in genetically engineered mouse models of breast cancer. J Biomed Opt 2005 0.90
26 Conditional over-expression of estrogen receptor alpha in a transgenic mouse model. Transgenic Res 2002 0.90
27 Regulation of progesterone receptor signaling by BRCA1 in mammary cancer. Nucl Recept Signal 2006 0.86
28 BRCA1 deficient mouse models to study pathogenesis and therapy of triple negative breast cancer. Breast Dis 2010 0.85
29 Methoxychlor induces atresia of antral follicles in ERalpha-overexpressing mice. Toxicol Sci 2006 0.85
30 Conditional mouse models demonstrate oncogene-dependent differences in tumor maintenance and recurrence. Breast Cancer Res 2003 0.84
31 Functional mimicry of the acetylated C-terminal tail of p53 by a SUMO-1 acetylated domain, SAD. J Cell Physiol 2010 0.84
32 Low-volume jet injection for intradermal immunization in rabbits. BMC Biotechnol 2002 0.82
33 Trp63 is regulated by STAT5 in mammary tissue and subject to differentiation in cancer. Endocr Relat Cancer 2014 0.82
34 Loss of protein phosphatase 2A expression correlates with phosphorylation of DP-1 and reversal of dysplasia through differentiation in a conditional mouse model of cancer progression. Cancer Res 2003 0.82
35 BAX is involved in regulating follicular growth, but is dispensable for follicle atresia in adult mouse ovaries. Reproduction 2007 0.80
36 Time-lapse imaging of primary preneoplastic mammary epithelial cells derived from genetically engineered mouse models of breast cancer. J Vis Exp 2013 0.80
37 The CDK4/6 inhibitor PD0332991 reverses epithelial dysplasia associated with abnormal activation of the cyclin-CDK-Rb pathway. Cancer Prev Res (Phila) 2012 0.79
38 Concurrent pregnancy retards mammary involution: effects on apoptosis and proliferation of the mammary epithelium after forced weaning of mice. Biol Reprod 2002 0.78
39 Chemoprevention of mammary carcinogenesis in a transgenic mouse model by alpha-difluoromethylornithine (DFMO) in the diet is associated with decreased cyclin D1 activity. Oncogene 2003 0.77
40 Genetically engineered ERα-positive breast cancer mouse models. Endocr Relat Cancer 2014 0.77
41 Early parity significantly elevates mammary tumor incidence in MMTV-c-myc transgenic mice. Transgenic Res 2003 0.77